Skip to content
Catalyst

sn-glycerol 3-phosphocholineFinding

Sn-glycerol 3-phosphocholine increases Montreal Cognitive Assessment total score

raisesVery limited evidenceFinding

01 · The sentence it was drawn from

“Adding choline alfoscerate to standard therapy significantly increased MoCA scores compared with control groups.”
Quoted verbatim from [Efficacy and clinical significance of choline alfoscerate in pre-dementia cognitive impairment. (A systematic review and meta-analysis of three randomized trials)].
This finding among the 3 findings on its endpoint

sn-glycerol 3-phosphocholine

Montreal Cognitive Assessment total score

raises

Who
Patients with mild to moderate cognitive impairment of vascular, degenerative or mixed etiology; choline alfoscerate added to standard therapy versus standard therapy alone, three pooled randomized trials
Dose studied
not reported

Very limited evidencePMID 42899920 · 2026

02 · The study

Study
meta-analysis
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

03 · The paper

Zhurnal nevrologii i psikhiatrii imeni S.S
What else it reported1 finding · 1 compound · 1 endpoint

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M6ZFAN61GA55C35Q4Z16D239